← Leaderboards
Anthony Shum
University Of California, San Francisco
$8,473,492
Attributed
$8,473,492
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,473,492 · 6
By mechanism
R01$6,954,579 · 3
R21$910,063 · 2
K08$608,850 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Mark S Anderson$96,401,564
- Alice Chan$1,044,916
- Michael R Waterfield$3,087,801
- Sara Vazquez$183,414
- Jiaxi Wang$119,803
Others in their field
Top investigators on “Syndrome”
- David Heimbrook · Leidos Biomedical Research, Inc.$365,165,418
- George R Seage · Abt Associates, Inc.$241,364,559
- Barbara Driver · Westat, Inc.$177,853,041
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$174,377,607
- Michelle Vargas · Ppd Development Lp$163,846,102
- Judith S. Currier · University Of California Los Angeles$149,333,820
Research focus
SyndromeMediatingLung DiseasesInterstitial Lung DiseasesAutoimmune DiseasesLungAutoantibodiesDefectProteinsCellsAutoimmunityT-LymphocyteImmuneAnimal ModelAnimalsAutoreactive T CellGenesGrantInsightLeadCytokineOrganAdoptive TransferImmune Tolerance
Grant awards (22)
Unraveling the molecular mechanisms of impaired central tolerance in COPA syndrome$629,882
R01 · FY2025 · AI · contact PI
Validating interferon score and phospho-STING level as disease biomarkers of COPA syndrome$462,188
R21 · FY2025 · TR · contact PI
Unraveling the molecular mechanisms of impaired central tolerance in COPA syndrome$656,632
R01 · FY2024 · AI · contact PI
Unraveling the molecular mechanisms of impaired central tolerance in COPA syndrome$687,433
R01 · FY2023 · AI · contact PI
Unraveling the molecular mechanisms of impaired central tolerance in COPA syndrome$690,613
R01 · FY2022 · AI · contact PI
Defining the Role of Thymic Tolerance in the Pathogenesis of the COPA syndrome$473,140
R01 · FY2022 · AI · contact PI
Defining the molecular mechanisms of COPA syndrome through computational modeling and functional studies$188,375
R21 · FY2022 · AI · contact PI
Defining the Role of Thymic Tolerance in the Pathogenesis of the COPA syndrome$473,140
R01 · FY2021 · AI · contact PI
Defining the molecular mechanisms of COPA syndrome through computational modeling and functional studies$259,500
R21 · FY2021 · AI · contact PI
Defining the Role of Thymic Tolerance in the Pathogenesis of the COPA syndrome$471,675
R01 · FY2020 · AI · contact PI
Defining the Role of Thymic Tolerance in the Pathogenesis of the COPA syndrome$469,478
R01 · FY2019 · AI · contact PI
Translational studies of autoimmune-mediated lung disease$393,196
R01 · FY2019 · HL · contact PI
Defining the Role of Thymic Tolerance in the Pathogenesis of the COPA syndrome$468,013
R01 · FY2018 · AI · contact PI
Translational studies of autoimmune-mediated lung disease$385,458
R01 · FY2018 · HL · contact PI
Translational studies of autoimmune-mediated lung disease$390,400
R01 · FY2017 · HL · contact PI
Translational studies of autoimmune-mediated lung disease$384,550
R01 · FY2016 · HL · contact PI
Translational studies of autoimmune-mediated lung disease$380,969
R01 · FY2015 · HL · contact PI
Mechanisms and Antigen Identification in a Novel Model of Autoimmune Lung Disease$121,770
K08 · FY2013 · HL · contact PI
Mechanisms and Antigen Identification in a Novel Model of Autoimmune Lung Disease$121,770
K08 · FY2012 · HL · contact PI
Mechanisms and Antigen Identification in a Novel Model of Autoimmune Lung Disease$121,770
K08 · FY2011 · HL · contact PI
Mechanisms and Antigen Identification in a Novel Model of Autoimmune Lung Disease$121,770
K08 · FY2010 · HL · contact PI
Mechanisms and Antigen Identification in a Novel Model of Autoimmune Lung Disease$121,770
K08 · FY2009 · HL · contact PI